We develop technology for multiple medical applications
TBS Osteo is powered by TBS iNsight, our medically
approved product, the gold standard in bone
microarchitecture assessment on DXA in osteoporosis.
We understand bone health
IDENTIFY
FINE-TUNE
IMPROVE
*Based on monitoring of changes of TBS across time
[PRESS RELEASE]Medical Reimbursement Now Available for Trabecular Bone Score (TBS), an Advanced Medtech Solution with Artificial Intelligence Capabilities, for Osteoporsis Fracture Risk Assessment
GENEVA--MEDIMAPS GROUP (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for the assessment of bone health, announced today…
Top 10 Trabecular Bone Score Articles in 2021
Top 10 TBS Articles in 2021 Get your copy of the Top 10 including 10 key takeaways and: Stay updated…
AHRA’s 50th Annual Meeting and Exposition
Join Medimaps Group (booth #721) at the AHRA’s 50th Annual Meeting and Exposition in Phoenix from July 10th to 13th…
2022 European Congress of Radiology
Join Medimaps Group (booth Expo X1 – 105) at the ECR 2022 in Vienna, Austria and online from July 13th – 17th,…
FRS & FRBMA
Join Medimaps Group at the 2022 Annual Meeting FRS & FRBMA to talk about the NEW reimbursement for Trabecular Bone Score…
2022 Santa Fe Bone Symposium
Join Medimaps Group (booth #101) at the 2022 Santa Fe Bone Symposium (New Mexico) to talk about the NEW reimbursement…
TBS iNsight serves as a foundation technology for tissue structure assessment software applications.
Leveraged first in the field of osteoporosis as the gold standard for bone microarchitecture assessment on DXA in osteoporosis – making a difference in patient lives.
Used in daily clinical routine in osteoporosis. Ongoing research shows its applicability in other medical fields.
TBS iNsight™ is a Medical Device that is CE 2797 (BSI) marked (cert. 715499) & 510(k) K152299 cleared in the US